Clinical Trial Update: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating two regimens for older patients with metastatic pancreatic cancer: gemcitabine plus nab-paclitaxel versus a regimen including 5-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Leucovorin (folinic acid)
• Liposomal irinotecan (liposomal irinotecan)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING